Retinal Organoids from Rhesus Macaque iPSCs
Source Lopez et al., 2022 · Department of Ophthalmology & Vision Science, School of Medicine, U.C. Davis · 10.1111/cpr.13198
Abstract
This protocol generates three-dimensional retinal organoids from rhesus macaque induced pluripotent stem cells (rhiPSCs) through a stepwise neural induction and retinal differentiation process. The resulting organoids develop laminated retinal tissue containing photoreceptors, Müller glia, bipolar cells, and other retinal cell types, with differentiation occurring approximately 30–40% faster than human iPSC-derived retinal organoids due to the shorter gestational period of rhesus macaques.
Protocol overview
22 steps across 4 phases
- 1 Generate rhesus macaque fibroblasts from skin punches
- 2 Transfect fibroblasts with reprogramming plasmids using Neon system
- 3 Culture transfected cells for 4–5 days
- 4 Maintain rhiPSC2431 colonies in defined xeno-free medium
- 5 Maintain rhiPSC89 and rhiPSC90 on MEF feeders
- 6 Maintain human H9 ESCs for comparison
- 1 Prepare iPSC colonies for differentiation
- 2 Treat colonies with dispase
- 3 Prepare neural induction media
- 4 Plate fragmented colonies in non-adherent conditions
- 5 Sequential weaning of EBs into neural induction media
- 6 Treat EBs with BMP4 on day 6
- 7 Plate EBs on Matrigel on day 7
- 8 Media changes on days 9 and 12
- 1 Media change to retinal differentiation media on day 15
- 2 Continue RDM media changes through day 30
- 3 Observe optic vesicle-like structures
- 4 Pick retinal organoids on day 30
- 1 Resuspend organoids in 3D retinal differentiation media
- 2 Culture organoids with RA supplementation until day 100
- 3 Culture organoids beyond day 100 without RA
- 4 Monitor morphological stages
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in Lopez et al., 2022. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol